GO:0010596 negative regulation of endothelial cell migration: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010596 describes any process that decreases the rate, frequency, or extent of endothelial cell movement into the extracellular matrix to form an endothelium.
• Negative regulation of endothelial cell migration is essential for vascular stabilization, and its dysregulation contributes to tumor angiogenesis, cardiac repair, and inflammatory disease.
• Key molecular players include VEGF/Notch signaling, G protein subunits, microRNAs, and secreted factors that modulate cytoskeletal dynamics and chemotaxis.
• Experimental models for studying this process include endothelial cell migration assays, knockout and overexpression cell lines, and CRISPR-based screens.
• Disease links include cancer (triple-negative breast cancer, hepatocellular carcinoma), cardiac injury, and hepatic ischemia-reperfusion injury.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models and library screening to dissect negative regulators of endothelial migration.
Description
Endothelial cell migration is a fundamental step in angiogenesis, wound healing, and vascular remodeling, and it must be tightly controlled to avoid pathological vessel formation. The Gene Ontology term GO:0010596, negative regulation of endothelial cell migration, captures the biological processes that decrease the rate, frequency, or extent of endothelial cell movement into the extracellular matrix to form an endothelium. This term is critical for researchers studying vascular biology because excessive or insufficient endothelial migration underlies diseases ranging from cancer to cardiac repair. Understanding the negative regulators of endothelial migration provides opportunities for therapeutic intervention in angiogenesis-dependent diseases.
negative regulation of endothelial cell migration At A Glance
| GO ID | GO:0010596 |
|---|---|
| GO term | negative regulation of endothelial cell migration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the rate, frequency, or extent of endothelial cell migration into the extracellular matrix to form an endothelium |
| Related processes | Angiogenesis, vascular stabilization, chemotaxis, cytoskeletal reorganization |
| Key signaling pathways | VEGF/Notch, G protein signaling, microRNA regulation, FAK-dependent chemotaxis |
| Disease relevance | Cancer, cardiac repair, hepatic ischemia-reperfusion injury, inflammatory diseases |
| Research methods | Migration assays, CRISPR screens, RNA-seq, proteomics, imaging |
What Is GO:0010596?
GO:0010596 is defined as any process that decreases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. In other words, it encompasses molecular and cellular events that put the brakes on endothelial cell migration, ensuring proper vascular patterning and preventing aberrant angiogenesis.
Why Is negative regulation of endothelial cell migration Important in Cell Biology?
Negative regulation of endothelial cell migration is essential for maintaining vascular homeostasis and preventing pathological angiogenesis. Dysregulation of this process is implicated in tumor progression, where cancer cells promote endothelial migration to support tumor vascularization, and in cardiovascular diseases where impaired endothelial migration hinders repair. Understanding the negative regulators provides targets for anti-angiogenic therapy and for promoting vascular regeneration.
• Controls angiogenesis and prevents excessive vessel formation.
• Dysregulation contributes to tumor angiogenesis and cancer progression.
• Plays a role in cardiac repair after injury.
• Involved in hepatic ischemia-reperfusion injury and liver endothelial heterogeneity.
• Modulated by microRNAs that negatively regulate angiogenesis.
• G protein subunit alpha i2 is pivotal in angiogenesis and endothelial migration.
• VEGF and Notch signaling regulate endothelial differentiation and arterial specification.
• FAK-dependent chemotaxis pathways affect endothelial diapedesis.
• Negative pressure can accelerate angiogenesis and alter migration-related gene expression.
• Provides therapeutic targets for anti-angiogenic and vascular regenerative strategies.
What Happens During negative regulation of endothelial cell migration?
Initiation of inhibitory signaling
In simple terms: The process starts when signals tell endothelial cells to slow down or stop moving.
Negative regulation of endothelial cell migration begins with extracellular cues such as VEGF gradients, Notch ligands, or microRNAs that activate inhibitory pathways. For example, Notch signaling downstream of VEGF can restrict endothelial tip cell formation and migration, thereby limiting sprouting angiogenesis. Similarly, specific microRNAs can directly target pro-migratory genes to suppress endothelial cell movement.
Cytoskeletal reorganization and adhesion dynamics
In simple terms: The cell's internal skeleton and attachment points are rearranged to reduce movement.
Inhibitory signals lead to changes in actin cytoskeleton dynamics and focal adhesion turnover, reducing the cell's ability to migrate. FAK-dependent chemotaxis pathways, when modulated, can alter endothelial diapedesis and migration. G protein subunit alpha i2 has been shown to play a pivotal role in angiogenesis, influencing endothelial cell migration and tube formation.
Modulation of gene expression
In simple terms: The cell changes which genes are turned on or off to put the brakes on migration.
Negative regulators often act by altering the expression of genes involved in proliferation and migration. For instance, triple-negative breast cancer cell-derived piR-31115 promotes endothelial cell proliferation and migration via METTL3-mediated m6A modification of YAP1, indicating that interfering with such pathways can negatively regulate migration. Negative pressure has been shown to regulate gene expression involved in proliferation and migration in HUVECs.
Stabilization of the endothelium
In simple terms: The final result is a more stable, less motile endothelial layer.
Ultimately, negative regulation of endothelial cell migration contributes to vascular stabilization by promoting cell-cell junctions and reducing sprouting. This is critical for resolving angiogenesis after injury and preventing excessive vessel growth. In cardiac repair, inhibition of Fap promotes cardiac repair by stabilizing BNP, which may involve modulation of endothelial migration.
Key Genes Involved in GO:0010596 negative regulation of endothelial cell migration
The following genes and proteins have been experimentally linked to the negative regulation of endothelial cell migration or related angiogenic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Regulates endothelial differentiation and arterial specification via Notch signaling | Key upstream modulator of endothelial migration |
| NOTCH1 | Mediates VEGF-induced negative regulation of tip cell migration | Critical for controlled angiogenesis |
| GNAI2 | G protein subunit alpha i2; pivotal role in angiogenesis | Regulates endothelial cell migration and tube formation |
| FAK (PTK2) | FAK-dependent chemotaxis pathways in endothelial diapedesis | Modulates endothelial migration and barrier function |
| YAP1 | Effector of m6A modification; promotes endothelial proliferation and migration | Target for negative regulation via METTL3 |
| METTL3 | m6A methyltransferase; modifies YAP1 mRNA | Epitranscriptomic regulator of endothelial migration |
| FAP | Inhibition promotes cardiac repair by stabilizing BNP | Potential negative regulator in cardiac endothelium |
| BNP (NPPB) | Stabilized by FAP inhibition; involved in cardiac repair | Cardiac endothelial protection |
| miRNAs (e.g., miR-1, miR-206) | Negative regulation of angiogenesis | Therapeutic targets for anti-angiogenic therapy |
| piR-31115 | Promotes endothelial proliferation and migration via METTL3/YAP1 | Oncogenic regulator in TNBC |
| HIF1A | Hypoxia-inducible factor; regulates angiogenesis | Implicated in liver endothelial heterogeneity |
| PECAM1 (CD31) | Endothelial cell junction protein | Marker of endothelial identity |
| CDH5 (VE-cadherin) | Endothelial adherens junction protein | Maintains endothelial barrier and reduces migration |
| KDR (VEGFR2) | VEGF receptor mediating angiogenic signals | Upstream of migration regulation |
| DLL4 | Notch ligand regulating tip cell selection | Negative regulator of endothelial sprouting |
| CXCR4 | Chemokine receptor involved in endothelial migration | Modulates chemotaxis |
| RHO GTPases | Regulate cytoskeletal dynamics during migration | Downstream effectors of inhibitory signals |
How Is negative regulation of endothelial cell migration Regulated?
Negative regulation of endothelial cell migration is controlled by a complex network of signaling pathways. VEGF and Notch signaling coordinate endothelial differentiation and arterial specification, with Notch activation acting as a negative feedback to limit tip cell migration. MicroRNAs can directly repress pro-migratory genes, thereby negatively regulating angiogenesis. G protein subunit alpha i2 (GNAI2) has been shown to be pivotal in angiogenesis, influencing endothelial cell migration. Additionally, FAK-dependent chemotaxis pathways modulate endothelial diapedesis and migration. Epigenetic modifications, such as METTL3-mediated m6A modification of YAP1, can also impact endothelial migration.
negative regulation of endothelial cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Triple-negative breast cancer angiogenesis | Knockout or overexpression in endothelial cells |
| FAP | Cardiac repair after injury | Knockout mouse models or cardiac endothelial cells |
| GNAI2 | Angiogenesis and vascular disease | Endothelial-specific knockout or overexpression |
| FAK (PTK2) | Inflammatory diapedesis and migration | Point mutation or knockout in endothelial cells |
| METTL3 | Cancer and epitranscriptomic regulation | Knockout or point mutation in endothelial cells |
Cancer and tumor angiogenesis
Negative regulation of endothelial cell migration is often subverted in cancer to promote tumor angiogenesis. Triple-negative breast cancer cell-derived piR-31115 promotes endothelial cell proliferation and migration via METTL3-mediated m6A modification of YAP1, indicating that disrupting this negative regulation supports tumor vascularization. Targeting such pathways could inhibit tumor growth by normalizing angiogenesis.
Cardiac repair and cardiovascular disease
In cardiac injury, inhibition of Fap promotes cardiac repair by stabilizing BNP, which may involve modulation of endothelial migration and angiogenesis. Proper negative regulation of endothelial migration is necessary to prevent excessive or insufficient vascularization after myocardial infarction.
Liver ischemia-reperfusion injury
Hepatic ischemia-reperfusion injury involves liver endothelial cell heterogeneity, and mitophagy-related genes have been predicted to play a role. Negative regulation of endothelial migration may influence endothelial resilience and repair in this context.
Inflammatory and infectious diseases
Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways, highlighting how pathogens can manipulate migratory machinery. Similar mechanisms may affect endothelial cells and contribute to vascular inflammation.
From negative regulation of endothelial cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate endothelial migration? | CRISPR knockout endothelial cell line |
| Does a specific mutation in gene X affect its inhibitory function? | Point mutation knock-in cell line |
| How does tagging gene X affect its localization during migration? | Tagged knock-in endothelial cells |
| Does overexpression of gene X reduce endothelial migration? | Overexpression cell model |
| Which genes are essential for negative regulation of migration? | CRISPR library screening in endothelial cells |
| What are the transcriptomic changes during inhibited migration? | RNA-seq of knockout vs wild-type endothelial cells |
How to Study the negative regulation of endothelial cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Assess negative regulation of endothelial migration |
| Scratch wound assay | Rate of cell migration into a gap | Evaluate inhibitory effects on migration |
| CRISPR knockout screening | Genes whose loss alters migration | Identify negative regulators |
| RNA-seq | Transcriptomic changes | Discover pathways affected by negative regulators |
| Proteomics | Protein expression and modifications | Identify downstream effectors |
| Live-cell imaging | Dynamic cytoskeletal changes | Visualize migration inhibition |
| Immunofluorescence | Localization of junctional proteins | Assess endothelial barrier stabilization |
| Tube formation assay | Angiogenic capacity in vitro | Measure functional consequences of migration inhibition |
Migration assays
Transwell and scratch wound assays are standard for measuring endothelial cell migration rates. These assays can be used to assess the effect of genetic perturbations on negative regulation of migration.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify negative regulators of endothelial cell migration. Such screens have been used to uncover genes involved in angiogenesis and migration.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal changes in gene expression and protein abundance following perturbation of candidate negative regulators. For example, negative pressure alters gene expression involved in proliferation and migration in HUVECs.
Imaging and live-cell analysis
Live-cell imaging of fluorescently tagged cytoskeletal or adhesion proteins allows real-time visualization of migration dynamics and the effects of negative regulators.
How CRISPR Can Be Used to Study GO:0010596 negative regulation of endothelial cell migration
Knockout
CRISPR knockout of candidate negative regulators can be used to determine whether their loss increases endothelial cell migration. For example, knocking out GNAI2 or FAK may enhance migration, confirming their inhibitory roles.
Point Mutation
Introducing specific point mutations in genes such as FAK or YAP1 can dissect the domains or phosphorylation sites required for negative regulation of endothelial migration.
Knock-in
Knock-in of tagged versions of proteins like VE-cadherin or GNAI2 allows tracking of their localization and dynamics during migration inhibition.
Overexpression
Overexpression of microRNAs or negative regulators such as certain miRNAs can suppress endothelial migration, providing gain-of-function evidence.
How EDITGENE Supports negative regulation of endothelial cell migration Research
Researchers studying negative regulation of endothelial cell migration-related genes often need to determine whether a candidate gene is causally involved in suppressing endothelial motility. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of endothelial cell migration research.
Frequently Asked Questions About negative regulation of endothelial cell migration
What is GO:0010596?
GO:0010596 is the Gene Ontology term for negative regulation of endothelial cell migration, defined as any process that decreases the rate, frequency, or extent of endothelial cell movement into the extracellular matrix to form an endothelium.
What genes are involved in negative regulation of endothelial cell migration?
Key genes include VEGFA, NOTCH1, GNAI2, FAK (PTK2), YAP1, METTL3, and various microRNAs that modulate endothelial motility.
How is negative regulation of endothelial cell migration studied?
Common methods include Transwell and scratch wound assays, CRISPR screens, RNA-seq, proteomics, and live-cell imaging.
Why is negative regulation of endothelial cell migration important in cancer?
In cancer, loss of negative regulation can promote tumor angiogenesis; for example, piR-31115 promotes endothelial migration via METTL3/YAP1 in triple-negative breast cancer.
What role does Notch signaling play in endothelial migration?
VEGF and Notch signaling coordinate endothelial differentiation and arterial specification, with Notch acting as a negative feedback to limit tip cell migration.
Can microRNAs negatively regulate endothelial cell migration?
Yes, specific microRNAs have been shown to negatively regulate angiogenesis by targeting pro-migratory genes.
What is the role of GNAI2 in angiogenesis?
G protein subunit alpha i2 (GNAI2) plays a pivotal role in angiogenesis, influencing endothelial cell migration and tube formation.
How does FAK affect endothelial migration?
FAK-dependent chemotaxis pathways modulate endothelial diapedesis and migration, and their inhibition can reduce migration.
What experimental models are used to study negative regulation of endothelial migration?
Models include CRISPR knockout, point mutation, knock-in, overexpression endothelial cell lines, and CRISPR library screens.
How can EDITGENE help with my research on endothelial migration?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, and library screening services tailored to study negative regulators of endothelial migration.
Conclusion
Negative regulation of endothelial cell migration (GO:0010596) is a critical biological process that maintains vascular homeostasis and prevents pathological angiogenesis. Dysregulation of this process contributes to cancer, cardiovascular disease, and inflammatory conditions. Understanding the molecular players and mechanisms provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR-based services to accelerate research in this field.
References
- 1. Sun Y et al.. 2023. Inhibition of Fap Promotes Cardiac Repair by Stabilizing BNP.. Circ Res 132(5):586-600 PMID: 36756875
- 2. Pan B et al.. 2024. Predicting mitophagy-related genes and unveiling liver endothelial cell heterogeneity in hepatic ischemia-reperfusion injury.. Front Immunol 15:1370647 PMID: 38694511
- 3. Delecluse S et al.. 2025. Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways.. Nat Commun 16(1):4581 PMID: 40389409
- 4. Fukui M et al.. 2022. Accelerated Angiogenesis of Human Umbilical Vein Endothelial Cells Under Negative Pressure Was Associated With the Regulation of Gene Expression Involved in the Proliferation and Migration.. Ann Plast Surg 89(6):e51-e59 PMID: 36416703
- 5. Bai CW et al.. 2024. G protein subunit alpha i2's pivotal role in angiogenesis.. Theranostics 14(5):2190-2209 PMID: 38505600
- 6. Hirashima M. 2009. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling.. Anat Sci Int 84(3):95-101 PMID: 19259767
- 7. Sanchez V et al.. 2019. Negative regulation of angiogenesis by novel micro RNAs.. Pharmacol Res 139:173-181 PMID: 30414893
- 8. Du SM et al.. 2025. Triple‑negative breast cancer cell‑derived piR‑31115 promotes the proliferation and migration of endothelial cells via METTL3‑mediated m6A modification of YAP1.. Oncol Rep 53(3) PMID: 39820521
